Federal Trade Commission v. Precision Patient Outcomes, Inc.; The Mailbag: Can Congress Impose Public Benefits Subject to Mandatory Arbitration

Published: April 21, 2023, 6:43 p.m.

b'

Federal Trade Commission v. Precision Patient Outcomes, Inc.

\\n

FTC\\u2019s lawsuit against Precision Patient Outcomes, Inc. (PPO), a California-based company which, among other things, develops dietary supplements, and its CEO, Margrett Lewis, is unlawful. NCLA argues FTC cannot rightfully exercise executive power by initiating and prosecuting this lawsuit, especially considering the Justice Department refused to bring this case. Congress cannot empower FTC Commissioners to file lawsuits while shielding them from at-will removal by the President.

\\n

Vec discusses FTC v. PPO.

\\n

The Mailbag: Can Congress Impose Public Benefits Subject to Mandatory Arbitration

\\n

Mark and Vec answer a submitted question on whether Congress can impose public benefits subject to mandatory arbitration.

See omnystudio.com/listener for privacy information.

'